Serfling, S.
Zhi, Y.
Schirbel, A.
Lindner, T.
Meyer, T.
Gerhard-Hartmann, E.
Lapa, C.
Hagen, R.
Hackenberg, S.
Buck, A. K.
Scherzad, A.
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 1 June 2020
Accepted: 24 September 2020
First Online: 15 October 2020
Compliance with ethical standards
:
: Patent application (EP 18155420.5) for quinolone-based FAP targeting agents in nuclear medicine (TL).
: Approved by the Ethic Committee of the Medical Faculty, University of Wuerzburg (123/19) for further immunohistopathological examination of FAP from resected tissues.
: Not applicable.
: Not applicable.
: Not applicable.